Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 78 hits in this display
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
Ki: 590nM ΔG°: -35.6kJ/molepH: 7.5 T: 2°CAssay Description:An Applied Photophysics stopped-flow instrument has been used for assaying the CA-catalyzed CO2 hydration activity [Khalifah et al., J. Biol. Chem., ...More data for this Ligand-Target Pair
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
Ki: 5.92E+3nM ΔG°: -29.8kJ/molepH: 7.5 T: 2°CAssay Description:An Applied Photophysics stopped-flow instrument has been used for assaying the CA-catalyzed CO2 hydration activity [Khalifah et al., J. Biol. Chem., ...More data for this Ligand-Target Pair
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
Ki: 9.06E+3nMAssay Description:Inhibition of human catalytic domain of carbonic anhydrase 12 preincubated for 15 mins by stopped-flow CO2 hydration assayMore data for this Ligand-Target Pair
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
Ki: 4.00E+5nM IC50: 1.20E+6nMAssay Description:The activity of EGFR, preactivated with EGF, is measured by its ability to transfer terminal phosphate from [gamma-32P]ATP to poly(GAT) substrate.More data for this Ligand-Target Pair
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
IC50: 21nMAssay Description:Inhibition of human recombinant MMP9 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 minsMore data for this Ligand-Target Pair
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
IC50: 24nMAssay Description:Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 minsMore data for this Ligand-Target Pair
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
IC50: 125nMAssay Description:Displacement of [125-I]-[Sar1, AngII from AT1R (unknown origin) expressed in Escherichia coli BL 21 (DE3) incubated for 2 hrs by radioimmunoassayMore data for this Ligand-Target Pair
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
IC50: 239nMAssay Description:Inhibition of human recombinant MMP1 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 minsMore data for this Ligand-Target Pair
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
Lipoxygenase(Solanum tuberosum (potato))University of Alberta
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
Lipoxygenase(Solanum tuberosum (potato))University of Alberta
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
Neuraminidase(Influenza A virus (strain A/Wilson-Smith/1933 H1N1...)National Taiwan University
Curated by ChEMBL
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
IC50: 1.31E+5nMAssay Description:Inhibition of recombinant bovine liver ARGI using L-arginine as substrate incubated for 60 mins by spectroscopic analysisMore data for this Ligand-Target Pair
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
IC50: 1.75E+6nMAssay Description:Inhibition of recombinant oligo-histidine-tagged Leishmania major DHODH expressed in Escherichia coli BL21(DE3) cells using DHO as substrate measured...More data for this Ligand-Target Pair
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
EC50: 2.16E+5nMAssay Description:Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic methodMore data for this Ligand-Target Pair
BDBM4375((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | (2...)
EC50: 9.70E+4nMAssay Description:Inhibition of TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of amyloid fibril formation by fluorescence assayMore data for this Ligand-Target Pair
Displayed 1 to 50 (of 78 total ) | Next | Last >>